The effect of granulocyte colony-stimulating factor (G-CSF) on the activity of granulocyte enzymes in children with cancer who developed neutropenia after chemotherapy

被引:0
作者
Czygier, M. [1 ]
Dakowicz, L. [2 ]
Szmitkowski, M. [1 ]
机构
[1] Med Univ Bialystok, Dept Biochem Diagnost, PL-15269 Bialystok, Poland
[2] J Sniadecki Dist Hosp, Dept Pediat, Bialystok, Poland
来源
ADVANCES IN MEDICAL SCIENCES | 2008年 / 53卷 / 02期
关键词
granulocyte-colony stimulating factor; neutropenia; cancer;
D O I
10.2478/v10039-008-0018-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose: G-CSF is a cytokine that stimulates the proliferation and maturation of granulocyte precursor cells. The results of in vitro and in vivo investigations conducted on animal models revealed that this cytokine influences the functions of mature granulocytes increasing the activities of the granulocyte enzymes participating in phagocytosis. Material and methods: The investigation was conducted on a group of 26 children (age: 1.5 - 17 years) with cancer who developed neutropenia after chemotherapy and were treated with G-CSF. The control group included 29 healthy children (age: 5 - 17 years). The heparinized blood samples were taken before the injection of the stimulator (time 0) and after the 2(nd) and 5(th) injection of G-CSF (on day 3 and 6). Activities of granulocyte enzymes involved in the process of phagocytosis (myeloperoxidase, acid and alkaline phosphatase and esterase) in blood smears were evaluated. Results: It has been found that G-CSF affects the activity of granulocyte enzymes by the normalization of decreased values of myeloperoxidase, acid phosphate and increasing the normal values of alkaline phosphate activity. The enzyme activities increased during the following days of treatment. Conclusion: Based on the obtained results, we can conclude that G-CSF activates the formation of fully competent granulocytes in cytostatic-treated children with various neoplastic diseases.
引用
收藏
页码:278 / 282
页数:5
相关论文
共 19 条
  • [1] THE EFFECT OF GM-CSF AND G-CSF ON HUMAN NEUTROPHIL FUNCTION
    BOBER, LA
    GRACE, MJ
    PUGLIESESIVO, C
    ROJASTRIANA, A
    WATERS, T
    SULLIVAN, LM
    NARULA, SK
    [J]. IMMUNOPHARMACOLOGY, 1995, 29 (02): : 111 - 119
  • [2] FASSAT C, 1994, STEM CELLS, V12, P322
  • [3] Elevation in plasma alkaline phosphatase level during rhG-CSF administration - Granulocytopenic patients with gynecologic cancers treated with cancer chemotherapy
    Fukumasu, H
    Fukumasu, Y
    Ogita, S
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1998, 45 (02) : 99 - 104
  • [4] Effect of granulocyte colony-stimulating factor treatment on ex vivo neutrophil functions in nonneutropenic surgical intensive care patients
    Gerber, A
    Struy, H
    Weiss, G
    Lippert, H
    Ansorge, S
    Schulz, HU
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2000, 20 (12) : 1083 - 1090
  • [5] EARLY STAGES OF ABSORPTION OF INJECTED HORSERADISH PEROXIDASE IN PROXIMAL TUBULES OF MOUSE KIDNEY - ULTRASTRUCTURAL CYTOCHEMISTRY BY A NEW TECHNIQUE
    GRAHAM, RC
    KARNOVSKY, MJ
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1966, 14 (04) : 291 - +
  • [6] Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and bacterial killing
    Hampton, MB
    Kettle, AJ
    Winterbourn, CC
    [J]. BLOOD, 1998, 92 (09) : 3007 - 3017
  • [7] Hoglund M, 1997, EUR J HAEMATOL, V58, P195
  • [8] In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro
    Leavey, PJ
    Sellins, KS
    Thurman, G
    Elzi, D
    Hiester, A
    Silliman, CC
    Zerbe, G
    Cohen, JJ
    Ambruso, DR
    [J]. BLOOD, 1998, 92 (11) : 4366 - 4374
  • [9] Liles W C, 2001, Semin Respir Infect, V16, P11
  • [10] Odajima T, 1998, MED SCI RES, V26, P291